TelyRx Holdings (TSX:TELY) Scaled Net Operating Assets: -0.02 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:TELY TelyRx Holdings Inc TSX:TELY
12 GF Score
Price C$2.60
! 1 Warning Sign
View Full Analysis

What is TelyRx Holdings Scaled Net Operating Assets?

TelyRx Holdings TSX:TELY +13.04% 12 Scaled Net Operating Assets is -0.02 as of Mar. 2026. GuruFocus rates TSX:TELY with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

TelyRx Holdings's operating assets for the quarter that ended in Mar. 2026 was C$9.88 Mil. TelyRx Holdings's operating liabilities for the quarter that ended in Mar. 2026 was C$10.12 Mil. TelyRx Holdings's Total Assets for the quarter that ended in Dec. 2025 was C$13.62 Mil. Therefore, TelyRx Holdings's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was -0.02.


TelyRx Holdings Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for TelyRx Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TelyRx Holdings Scaled Net Operating Assets Chart

TelyRx Holdings Annual Data
Trend Dec23 Dec24 Dec25
Scaled Net Operating Assets
0.41 0.28 0.05

TelyRx Holdings Quarterly Data
Dec23 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial 0.00 0.00 0.00 0.05 -0.02

TelyRx Holdings Scaled Net Operating Assets Competitor Comparison

For the Pharmaceutical Retailers subindustry, TelyRx Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TelyRx Holdings Scaled Net Operating Assets vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TelyRx Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where TelyRx Holdings's Scaled Net Operating Assets falls into.


TSX:TELY
12GF Score
TelyRx Holdings Inc TSX:TELY
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TelyRx Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

TelyRx Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(9.502-8.943)/11.324
=0.05

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=13.624 - 4.122
=9.502

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=25.314 - 3.489 - 12.882
=8.943

TelyRx Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(9.878-10.118)/13.624
=-0.02

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=46.918 - 37.04
=9.878

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=27.681 - 17.161 - 0.402
=10.118

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -0.02 mean?
TelyRx Holdings (TSX:TELY) has a Scaled Net Operating Assets of -0.02 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on TelyRx Holdings and its competitors.
Is TelyRx Holdings' Scaled Net Operating Assets too high?
TelyRx Holdings' current Scaled Net Operating Assets is -0.02. Overall, TelyRx Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TelyRx Holdings' Scaled Net Operating Assets compare to competitors?
TelyRx Holdings' Scaled Net Operating Assets of -0.02 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Healthcare Providers & Services company?
A good Scaled Net Operating Assets depends on the Healthcare Providers & Services industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on TelyRx Holdings and its competitors. TelyRx Holdings's current Scaled Net Operating Assets is -0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TelyRx Holdings stock overvalued right now?
TelyRx Holdings (TSX:TELY) has a current Scaled Net Operating Assets of -0.02. The current Scaled Net Operating Assets is -0.02. TelyRx Holdings' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For TelyRx Holdings (TSX:TELY), the current Scaled Net Operating Assets is -0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TelyRx Holdings Business Description

Address 24761 US Highway 19 North, Clearwater, FL, USA, 33763
TelyRx Holdings Inc is a vertically integrated technology enabled healthcare and pharmacy services provider, operating a digital pharmacy platform that connects patients with independent, state-licensed providers. The TelyRx platform provides the Providers with access to a clinically focused electronic medical records system and the ability for them to electronically prescribe. TelyRx enables patient access to a risk-curated formulary of over 450 noncontrolled, and non-compounded prescription medications selected by the Providers to address a broad cross-section of everyday chronic and acute ailments.
12GF Score

Get the complete analysis for TSX:TELY

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$2.60
Price